NCT03139747 2021-10-15UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib AloneThomas Jefferson UniversityPhase 2 Suspended5 enrolled